Clinical Trials
19 trialsInduction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Tianjin Medical University Cancer Institute and Hospital
Induction Chemotherapy for Locally Advanced Esophageal Cancer
University of Rochester
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
The First Affiliated Hospital with Nanjing Medical University
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
CELAEC
The First Affiliated Hospital of Henan University of Science and Technology
The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SFP OES
University Medical Center Groningen
Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer
Capital Medical University
Prediction Model of Response for CCRT in Esophageal Cancer
Kyungpook National University Hospital
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
National Institutes of Health Clinical Center (CC)
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
Russian Academy of Medical Sciences
Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC
Tianjin Medical University Cancer Institute and Hospital
Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer
Changzhou No.2 People's Hospital
FOLFOX
Assistance Publique - Hôpitaux de Paris
Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)
Chinese University of Hong Kong